Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01DA014979 | U.S. NIH Grant/Contract | View source | |
| DPMCDA |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
For the past several years our research program has developed and tested an intensive outpatient intervention that is based in social learning theory and employs abstinence contingent access to recovery housing as a routine aspect of an intensive day treatment counseling program. The present project proposes to extend this treatment intervention to the special population of pregnant drug using women enrolled at the Center for Addiction and Pregnancy (CAP). We will compare an enhanced treatment that includes abstinence contingent recovery house living plus intensive individual therapy, to standard care at the CAP program. Specific aims of the project are derived from testing a two-group design are described below:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | receives housing based on drug abstinence |
|
| 2 | Active Comparator | Usual care treatment at the Center for Addiction and Pregnancy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RBT | Behavioral | Contingency management and behavioral counseling including motivational interviewing |
|
| Measure | Description | Time Frame |
|---|---|---|
| Treatment retention, drug free urine samples at follow-up and delivery | treatment entry until 12 months post treatment entry |
| Measure | Description | Time Frame |
|---|---|---|
| prenatal care compliance, neonatal and birth outcomes | treatment entry until 12 months post treatment entry |
Not provided
Inclusion Criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hendree E Jones, PhD | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Addiction and Pregnancy Jhons Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | United States |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D009357 | Neonatal Abstinence Syndrome |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D007232 | Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| usual care | Behavioral | receives usual comprehensive care at Center for Addiction and Pregnancy |
|